Home > Newsletters > FDAnews Device Daily Bulletin > Patent Experts, Venture Capitalists at Odds Over Impact of Prometheus
FDAnews Device Daily Bulletin
June 1, 2012 | Vol. 9 No. 108
Patent Experts, Venture Capitalists at Odds Over Impact of Prometheus
Two months after the Supreme Court’s ruling in Mayo v. Prometheus, investment dollars are still flowing into biotech initiatives, but legal experts say the real ramifications of that decision could be years away. During a recent The George Washington University School of Law-Biotechnology Industry Organization (GWU-BIO) roundtable, a group of mostly patent attorneys warned that the May 20 High Court decision could have a chilling effect on venture capital investment in biotechnology.
Devices & Diagnostics Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.